ATE257159T1 - Oral wirksame androgene - Google Patents

Oral wirksame androgene

Info

Publication number
ATE257159T1
ATE257159T1 AT00953032T AT00953032T ATE257159T1 AT E257159 T1 ATE257159 T1 AT E257159T1 AT 00953032 T AT00953032 T AT 00953032T AT 00953032 T AT00953032 T AT 00953032T AT E257159 T1 ATE257159 T1 AT E257159T1
Authority
AT
Austria
Prior art keywords
oral androgens
androgens
oral
Prior art date
Application number
AT00953032T
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Dirk Leysen
Der Louw Jaap Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE257159T1 publication Critical patent/ATE257159T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00953032T 1999-07-16 2000-07-10 Oral wirksame androgene ATE257159T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202348 1999-07-16
PCT/EP2000/006544 WO2001005806A1 (en) 1999-07-16 2000-07-10 Orally active androgens

Publications (1)

Publication Number Publication Date
ATE257159T1 true ATE257159T1 (de) 2004-01-15

Family

ID=8240463

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00953032T ATE257159T1 (de) 1999-07-16 2000-07-10 Oral wirksame androgene

Country Status (28)

Country Link
US (3) US6313108B1 (de)
EP (1) EP1203011B1 (de)
JP (1) JP2003505394A (de)
KR (1) KR20020092890A (de)
CN (1) CN1360589A (de)
AR (1) AR024746A1 (de)
AT (1) ATE257159T1 (de)
AU (1) AU770412B2 (de)
BR (1) BR0012489A (de)
CA (1) CA2379223A1 (de)
CO (1) CO5200765A1 (de)
CZ (1) CZ2002192A3 (de)
DE (1) DE60007530T2 (de)
ES (1) ES2213596T3 (de)
HK (1) HK1043797A1 (de)
HU (1) HUP0201952A3 (de)
IL (1) IL147332A0 (de)
MX (1) MXPA02000601A (de)
NO (1) NO20020222L (de)
NZ (1) NZ516525A (de)
PE (1) PE20010330A1 (de)
PL (1) PL353007A1 (de)
RU (1) RU2002103883A (de)
SK (1) SK712002A3 (de)
TR (1) TR200200076T2 (de)
TW (1) TW548277B (de)
WO (1) WO2001005806A1 (de)
ZA (1) ZA200200106B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
ATE334682T1 (de) * 2000-03-31 2006-08-15 Us Gov Health & Human Serv Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
BR0112791A (pt) * 2000-07-28 2003-06-24 Akzo Nobel Nv Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica
ATE321557T1 (de) * 2001-03-30 2006-04-15 Us Gov Health & Human Serv Verfahren zur herstellung von 7alpha,11beta- dimethyl-17beta-hydroxyestra-4, 14-dien-3-one, dessen 17-ester und pharmazeutische zubereitungen die sie enthalten
KR100937179B1 (ko) * 2002-01-21 2010-01-19 엔.브이.오가논 7α-메틸스테로이드의 제조방법
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP2350111A1 (de) * 2008-10-15 2011-08-03 Synthon B.V. Verfahren und zwischenprodukte zur herstellung von fulvestrant
AU2012264602B2 (en) 2011-06-01 2017-03-09 Estetra Srl Process for the production of estetrol intermediates
WO2012164095A1 (en) * 2011-06-01 2012-12-06 Estetra S.A. Process for the production of estetrol intermediates
EP2383279A1 (de) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Herstellungsverfahren für Esterol
AU2012320423C1 (en) * 2011-10-07 2018-01-25 Estetra Srl Process for the production of estetrol
WO2015181116A1 (en) 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
US20160367567A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
UA123099C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована в порожнині рота одиниця дозування, яка містить естетрольний компонент
HRP20210668T1 (hr) 2015-06-18 2021-05-28 Estetra Sprl Orodisperzibilna tableta koja sadrži estetrol
MD3310346T2 (ro) 2015-06-18 2021-06-30 Estetra Sprl Comprimată orodispersabilă ce conține estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
ES2906117T3 (es) * 2017-02-23 2022-04-13 Siemens Healthcare Diagnostics Inc Conjugados de androstenodiona quimioluminiscente
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA712312B (en) * 1970-04-28 1972-01-26 Ochsner Med Found Alton 4,14-estradiene compounds

Also Published As

Publication number Publication date
DE60007530D1 (de) 2004-02-05
CZ2002192A3 (cs) 2002-06-12
TR200200076T2 (tr) 2002-04-22
HUP0201952A3 (en) 2003-10-28
RU2002103883A (ru) 2004-02-27
SK712002A3 (en) 2002-06-04
US20020022609A1 (en) 2002-02-21
ZA200200106B (en) 2003-06-25
BR0012489A (pt) 2002-04-02
WO2001005806A1 (en) 2001-01-25
AU770412B2 (en) 2004-02-19
US6780854B2 (en) 2004-08-24
CO5200765A1 (es) 2002-09-27
NO20020222L (no) 2002-01-25
IL147332A0 (en) 2002-08-14
HK1043797A1 (zh) 2002-09-27
EP1203011A1 (de) 2002-05-08
PE20010330A1 (es) 2001-03-22
NO20020222D0 (no) 2002-01-15
TW548277B (en) 2003-08-21
HUP0201952A2 (en) 2002-10-28
DE60007530T2 (de) 2004-12-23
US20030087886A1 (en) 2003-05-08
MXPA02000601A (es) 2002-07-30
ES2213596T3 (es) 2004-09-01
JP2003505394A (ja) 2003-02-12
US6313108B1 (en) 2001-11-06
US6541465B2 (en) 2003-04-01
KR20020092890A (ko) 2002-12-12
CA2379223A1 (en) 2001-01-25
CN1360589A (zh) 2002-07-24
AU6562900A (en) 2001-02-05
NZ516525A (en) 2003-06-30
EP1203011B1 (de) 2004-01-02
AR024746A1 (es) 2002-10-23
PL353007A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
ATE257159T1 (de) Oral wirksame androgene
DK1308108T3 (da) Tandbörste
DE60009127D1 (de) Zahnbürste
EE200100502A (et) Ühendid
DE10084676T1 (de) Einmallanzettvorrichtung
ATA51899A (de) Handstempel
ATE264633T1 (de) Zahnbürste
DE10084428T1 (de) Zahnbürste
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE50009595D1 (de) Zahnbürste
ID29533A (id) Senyawa-senyawa kalsilitik
DE50006709D1 (de) Zahnbürste
ID30397A (id) Larutan oral prukaloprida
NO20020466D0 (no) Kalsilytiske forbindelser
DE10085008T1 (de) Oberflächenbehandlungsdüse
NO20014262D0 (no) Tiazoloindolinon-forbindelser
ATE440824T1 (de) Nitro-sulfobenzamide
DE10082008D2 (de) Ausbeulgerät
ATE269311T1 (de) Benzoylpyridazine
DE60020365D1 (de) Säurekatalysierte umsetzungen
ID29984A (id) Senyawa-senyawa bis-stirilbifenil
DE69920485D1 (de) Ringösendreher
ATA107599A (de) Heizwasserbereiter
AT500658A3 (de) Isolierplatte

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties